Wall Street is positive on Kura Oncology Inc (KURA). On average, analysts give KURA a Strong Buy rating. The average price target is $38.2, which means analysts expect the stock to add by 208.06% over the next twelve months.
That average ranking earns KURA an Analyst Rating of 72, which is better than 72% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating KURA a Strong Buy today. Find out what this means to you and get the rest of the rankings on KURA!
You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers.
InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.
What's Happening With Kura Oncology Inc Stock Today?
Kura Oncology Inc (KURA) stock is trading at $12.40 as of 11:04 AM on Tuesday, May 10, a gain of $0.88, or 7.64% from the previous closing price of $11.52. The stock has traded between $12.14 and $13.29 so far today. Volume today is below average. So far 363,278 shares have traded compared to average volume of 499,187 shares.
Click Here to get the full Stock Report for Kura Oncology Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
